Skip to main content
Diabetes logoLink to Diabetes
. 2021 Oct 29;71(1):171. doi: 10.2337/db22-er01b

Erratum. SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans. Diabetes 2021;70:2364–2376

Harunobu Nishizaki, Osamu Matsuoka, Tomoya Kagawa, Akihiro Kobayashi, Masanori Watanabe, Yusuke Moritoh
PMCID: PMC8978616  PMID: 34716201

In Table 2 of the above-cited article, the data column for placebo group (N = 20) for the single ascending dose (SAD) part of the study did not fall under the SAD column heading due to a composition error. The SAD part of the study included this placebo group.

The editors apologize for the error.

The online version of the article (https://doi.org/10.2337/db21-0451) has been updated to correct the error.


Articles from Diabetes are provided here courtesy of American Diabetes Association

RESOURCES